In non‐CKD patients with osteoporosis, relationships between miRNAs and histomorphometry have been reported,20 and dysregulation in levels of circulating miRNA expression has been associated with osteoporosis21, 22, 23 and fractures.24, 25 In CKD patients, levels of miRNAs and PTH have been correlated26; in cell culture, inorganic phosphate was shown to modulate osteoclastogenesis by miRNA‐233.27 miRNAs have not been tested as biomarkers of turnover in CKD. The gene discussed is PTH; the disease is chronic kidney disease.